Use of FMF algorithm for prediction of preeclampsia in high risk pregnancies: a single center longitudinal study

References

• Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol. 2000;95(1):24–28.
   PubMed Web of Science ®Google Scholar
• Garovic VD, White WM, Vaughan L, et al. Incidence and Long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020;75(18):2323–2334.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Keyes KM, Wapner RJ. Preeclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564.
   PubMed Web of Science ®Google Scholar
• Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299–1306.
   PubMed Web of Science ®Google Scholar
• Youssef A, Righetti F, Morano D, et al. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11+0 to 13+6 weeks in the prediction of late (>34 weeks) pre-eclampsia. PrenatDiagn. 2011;31(12):1141–1146.
   Google Scholar
• Di Lorenzo G, Ceccarello M, Cecotti V, et al. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta. 2012;33(6):495–501.
   PubMed Web of Science ®Google Scholar
• Poon LC, Kametas NA, Maiz N, et al. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53(5):812–818.
   PubMed Web of Science ®Google Scholar
• Poon LC, Shennan A, Hyett JA, et al. Erratum to “The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention”. Int J Gynaecol Obstet. 2019;146(3):390–391.
   PubMed Web of Science ®Google Scholar
• ACOG. First-trimester risk assessment for early-onset preeclampsia. Committee opinion No. 638. ObstetGynecol. 2015;126:e25–27.
   Google Scholar
• Poon LC, Kametas NA, Chelemen T, et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24(2):104–110.
   PubMed Web of Science ®Google Scholar
• National Collaborating Center for Women’s and Children’s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: Royal College of Obstetricians and Gynecologists, Press; 2010.
   Google Scholar
• American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy, 2013. Available from: https://www.acog.org/~/media/Task%20Force%20and%20Work%20Group%20Reports/public/HypertensioninPregnancy.pdf.
   Google Scholar
• Tolcher MC, Chu DM, Hollier LM, et al. Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia. Am J Obstet Gynecol. 2017;217(3):365.e1–365.e8.
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion No. 743: low-Dose Aspirin Use During Pregnancy. Obstet Gynecol. 2018;132(1):e44–e52. American College of Obstetricians and Gynecologists.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Poon L, et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8–15.
   PubMed Web of Science ®Google Scholar
• Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62.e1–62.e10.
   Web of Science ®Google Scholar
• O’Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1–103.e12.
   PubMed Web of Science ®Google Scholar
• Krantz DA, Hallahan TW. Incorporating the probability of competing event(s) into the preeclampsia competing risk algorithm. Am J Obstet Gynecol. 2019;221(5):533–534.
   PubMed Web of Science ®Google Scholar
• Roberts L, Chaemsaithong P, Sahota DS, et al. Protocol for measurement of mean arterial pressure at 10-40 weeks' gestation. Pregnancy Hypertens. 2017;10:155–160.
   PubMed Web of Science ®Google Scholar
• Plasencia W, Maiz N, Bonino S, et al. Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30(5):742–749.
   PubMed Web of Science ®Google Scholar
• Gómez O, Figueras F, Fernández S, et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32(2):128–132.
   PubMed Web of Science ®Google Scholar
• Thomas E, Caruhel P Performances of the Thermo Scientific BRAHMS sFlt-1 KRYPTOR assay - preliminary results. 2013.
   Google Scholar
• Tan MY, Wright D, Syngelaki A, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018;51(6):743–750.
   PubMed Web of Science ®Google Scholar
• Gallo DM, Wright D, Casanova C, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks’ gestation. Am J Obstet Gynecol. 2016;214(5):619.e1–619.e17.
   PubMed Web of Science ®Google Scholar
• Chaemsaithong P, Sahota D, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2020;S0002-9378(20)30741–9.
   Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int. 2014;2014:297397.
   PubMedGoogle Scholar
• Al-Rubaie Z, Askie LM, Ray JG, et al. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review. BJOG. 2016;123(9):1441–1452.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther. 2011;29(3):183–196.
   PubMed Web of Science ®Google Scholar
• Mosimann B, Amylidi-Mohr SK, Surbek D, et al. First trimester screening for preeclampsia - A systematic review. Hypertens Pregnancy. 2020;39(1):1–11.
   PubMed Web of Science ®Google Scholar
• Jelliffe-Pawlowski LL, Baer RJ, Currier RJ, et al. Early-onset severe preeclampsia by first trimester pregnancy-associated plasma protein A and total human chorionic gonadotropin. Am J Perinatol. 2015;32(7):703–712.
   PubMed Web of Science ®Google Scholar
• Liu HQ, Wang YH, Wang LL, et al. Predictive value of free β-hCG multiple of the median for women with preeclampsia. Gynecol Obstet Invest. 2016;81(2):137–147.
   Web of Science ®Google Scholar
• Olsen RN, Woelkers D, Dunsmoor-Su R, et al. Abnormal second trimester serum analytes are more predictive of preterm preeclampsia. Am J Obstet Gynecol. 2012;207(3):228.e1–7.
   Web of Science ®Google Scholar
• Abdel Moety GA, Almohamady M, Sherif NA, et al. Could first-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study. J Matern Fetal Neonatal Med. 2016;29(3):413–417.
   PubMed Web of Science ®Google Scholar
• Asvold BO, Eskild A, Vatten LJ. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study. Acta Obstet Gynecol Scand. 2014;93(5):454–462.
   PubMed Web of Science ®Google Scholar
• Gallo D, Poon LC, Fernandez M, et al. Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks’ gestation. Fetal Diagn Ther. 2014;36(1):28–37.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn. 2011;31(1):66–74.
   PubMed Web of Science ®Google Scholar
• Tayyar A, Garcia-Tizon Larroca S, Poon LC, et al. Competing risk model in screening for pre-eclampsia by mean arterial pressure and uterine artery pulsatility index at 30–33 weeks’gestation. Fetal Diagn Ther. 2014;36(1):18–27.
   PubMed Web of Science ®Google Scholar
• Crispi F, Llurba E, Domínguez C, et al. Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;31(3):303–309.
   PubMed Web of Science ®Google Scholar
• Foidart JM, Munaut C, Chantraine F, et al. Maternal plasmasoluble endoglin at 11-13 weeks’ gestation in pre-eclampsia. Ultrasound Obstet Gynecol. 2010;35(6):680–687.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Espinoza J, et al. The change in concentrations of angiogenic and anti angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008;21(5):279–287.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Eskild A, Nilsen TI, et al. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol. 2007;196(3):239.e1–6.
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9–23.
   PubMed Web of Science ®Google Scholar
• Mikat B, Zeller A, Scherag A, et al. βhCG and PAPP-A in first trimester: predictive factors for preeclampsia. Hypertens Pregnancy. 2012;31(2):261–267.
   PubMed Web of Science ®Google Scholar
• Costa Fda S, Murthi P, Keogh R, et al. Early screening for preeclampsia. Rev Bras Ginecol Obstet. 2011;33(11):367–375.
   PubMedGoogle Scholar
• Park HJ, Shim SS, Cha DH. Combined screening for early detection of pre-eclampsia. Int J Mol Sci. 2015;16(8):17952–17974.
   PubMed Web of Science ®Google Scholar
• Wu P, Van Den Berg C, Alfirevic Z, et al. Early pregnancy biomarkers in pre-eclampsia: a systematic review and meta-analysis. Int J Mol Sci. 2015;16(9):23035–23056.
   PubMed Web of Science ®Google Scholar
• Boucoiran I, Thissier-Levy S, Wu Y, et al. MIROS study group. Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies. Am J Perinatol. 2013;30(7):607–612.
   PubMed Web of Science ®Google Scholar
• Myatt L, Clifton RG, Roberts JM, et al. Eunice kennedy shriver national institute of child health and human development (NICHD) maternal-fetal medicine units (MFMU) network. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol. 2012;119(6):1234–1242.
   PubMed Web of Science ®Google Scholar
• Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2013;153(1):13–19.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206(1):58.e1–8.
   PubMed Web of Science ®Google Scholar
• Rezende KBC, Cunha AJLAD, Amim Junior J, et al. External validation of the fetal medicine foundation algorithm for the prediction of preeclampsia in a Brazilian population. Pregnancy Hypertens. 2019;17:64–68.
   PubMed Web of Science ®Google Scholar
• Guizani M, Valsamis J, Dutemeyer V, et al. First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the fetal medicine foundation-algorithm. Fetal Diagn Ther. 2018;43(4):266–273.
   PubMed Web of Science ®Google Scholar
• De Kat AC, Hirst J, Woodward M, et al. Prediction models for preeclampsia: a systematic review. Pregnancy Hypertens. 2019;16:48–66.
   PubMed Web of Science ®Google Scholar
• Tan MY, Syngelaki A, Poon LC, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2018;52(2):186–195.
   PubMed Web of Science ®Google Scholar